Filing Flows › Gyre Therapeutics (GYRE) › How it makes money
How Gyre Therapeutics (GYRE) makes money
Gyre Therapeutics (GYRE) made $32.9M of revenue in the third quarter 2026 (Q3 2026), +0.7% from a year earlier. Gyre Pharmaceuticals brought in $32.4M (98%); Gyre brought in $508K (2%).
Drawing the Sankey…
Revenue by segment, Q3 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Gyre Pharmaceuticals | $32.4M | 98.5% | +11% | +6% |
| Gyre | $508K | 1.5% | 64× | -76% |
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $32.9M | 100.0% |
| Income tax | $733K | 2.2% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $32.9M | +0.7% |
| Q2 2026 | $29.1M | -2% |
| Q1 2026 | $22.5M | +2% |
| Q4 2025 | $37.2M | +33% |
| Q3 2025 | $30.6M | +20% |
| Q2 2025 | $26.8M | +6% |
| Q1 2025 | $22.1M | -19% |
From Gyre Therapeutics' 10-Q filed Nov 6, 2026 (on EDGAR).
Questions
How does Gyre Therapeutics make money?
Gyre Therapeutics (GYRE) made $32.9M of revenue in the third quarter 2026 (Q3 2026), +0.7% from a year earlier. Gyre Pharmaceuticals brought in $32.4M (98%); Gyre brought in $508K (2%).
What is Gyre Therapeutics' biggest business?
Gyre Pharmaceuticals: $32.4M in the third quarter 2026, 98% of revenue, +6% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.